Characterization of a Prospective Cohort of Women With PCOS

NCT02010814 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2023-04-25

No results posted yet for this study

Summary

Polycystic ovary syndrome (PCOS) is a common endocrine disorder in premenopausal women. PCOS is characterized by increase levels of testosterone, unwanted hair growth, adiposity, irregular menstrual cycle, and infertility. PCOS is associated with diabetes mellitus and cardiovascular diseases. Women with PCOS are reported to have increased levels of stress hormones, which may be associated with decreased quality of life. Increased testosterone levels in women may decrease the risk of osteoporosis. The aim of the present study is to measure levels of stress hormones in urine and describe quality of life using questionnaires. In addition we aim to characterize body composition and bone architecture using DXA and ExtremeCT.

As part of the project, a Biobank with fasting blood samples from participants is established.

Conditions

  • Polycystic Ovary Syndrome

Sponsors & Collaborators

  • Odense University Hospital

    lead OTHER

Principal Investigators

  • Dorte Glintborg, MD PhD · Department of Endocrinology, Odense University Hospital

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-01-01
Primary Completion
2027-01-01
Completion
2028-01-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02010814 on ClinicalTrials.gov